ESSA Pharma Inc.

2.89-0.1200-3.99%Vol 419.36K1Y Perf -79.65%
Aug 11th, 2022 16:00 DELAYED
BID2.85 ASK2.96
Open3.08 Previous Close3.01
Pre-Market- After-Market2.86
 - -  -0.03 -1.04%
Target Price
23.00 
Analyst Rating
Strong Buy 1.00
Potential %
695.85 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
2.99 
Earnings Rating
Strong Buy
Market Cap86.78M 
Earnings Date
15th Aug 2022
Alpha-0.01 Standard Deviation0.25
Beta1.71 

Today's Price Range

2.873.13

52W Range

2.4118.45

5 Year PE Ratio Range

-5.20-1.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-3.67%
1 Month
16.53%
3 Months
-48.48%
6 Months
-69.74%
1 Year
-79.65%
3 Years
71.01%
5 Years
702.78%
10 Years
-

TickerPriceChg.Chg.%
EPIX2.89-0.1200-3.99
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.27-0.2025.93
Q02 2022-0.25-0.250.00
Q01 2022-0.23-0.218.70
Q04 2021-0.23-0.2013.04
Q03 2021-0.26-0.2119.23
Q02 2021-0.21-0.36-71.43
Q01 2021-0.17-0.20-17.65
Q04 2020-0.20-0.1715.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.276.90Positive
9/2022 QR-0.306.25Positive
9/2022 FY-1.024.67Positive
9/2023 FY-1.1910.53Positive
Next Report Date15th Aug 2022
Estimated EPS Next Report-0.27
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume419.36K
Shares Outstanding30.03K
Shares Float38.18M
Trades Count1.68K
Dollar Volume1.25M
Avg. Volume448.68K
Avg. Weekly Volume255.23K
Avg. Monthly Volume697.35K
Avg. Quarterly Volume393.46K

ESSA Pharma Inc. (NASDAQ: EPIX) stock closed at 2.89 per share at the end of the most recent trading day (a -3.99% change compared to the prior day closing price) with a volume of 419.36K shares and market capitalization of 86.78M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 25 people. ESSA Pharma Inc. CEO is David R. Parkinson.

The one-year performance of ESSA Pharma Inc. stock is -79.65%, while year-to-date (YTD) performance is -79.65%. EPIX stock has a five-year performance of 702.78%. Its 52-week range is between 2.41 and 18.45, which gives EPIX stock a 52-week price range ratio of 2.99%

ESSA Pharma Inc. currently has a PE ratio of -3.60, a price-to-book (PB) ratio of 0.78, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -18.98%, a ROC of -19.59% and a ROE of -19.40%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from ESSA Pharma Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.27 for the next earnings report. ESSA Pharma Inc.’s next earnings report date is 15th Aug 2022.

The consensus rating of Wall Street analysts for ESSA Pharma Inc. is Strong Buy (1), with a target price of $23, which is +695.85% compared to the current price. The earnings rating for ESSA Pharma Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ESSA Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ESSA Pharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 42.03, ATR14 : 0.32, CCI20 : -37.80, Chaikin Money Flow : -0.01, MACD : -0.15, Money Flow Index : 52.22, ROC : -0.69, RSI : 24.83, STOCH (14,3) : 37.25, STOCH RSI : 0.75, UO : 40.90, Williams %R : -62.75), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ESSA Pharma Inc. in the last 12-months were: David Ross Parkinson (Buy at a value of $14 456)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

CEO: David R. Parkinson

Telephone: +1 778 331-0962

Address: 999 West Broadway Street, Vancouver V5Z 1K5, BC, CA

Number of employees: 25

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

53%47%

Bearish Bullish

55%45%

Bearish Bullish

61%39%

TipRanks News for EPIX

Tue, 28 Jun 2022 14:06 GMT ESSA Pharma (EPIX) Gets a Buy Rating from Bloom Burton

- TipRanks. All rights reserved.

News

Stocktwits